Functional Diagnostics in Wisconsin

Imaging Biometrics develops quantitative medical imaging analysis software focused on neuro-oncology and brain tumor characterization. The company specializes in advanced post-processing algorithms and plugins that enhance MRI interpretation, particularly for contrast-enhanced imaging and perfusion analysis. Core product offerings include FTB Maps (for tumor characterization), IB Nimble (clinical workflow integration), IB Neuro (neuroimaging analysis with Delta T1 and rCBV mapping), IB Diffusion, IB DCE (dynamic contrast-enhanced imaging), IB Delta Suite, IB Rad Tech, and IB StoneChecker. The software leverages proprietary quantitative technology including Delta T1 (standardized T1 subtraction) and relative cerebral blood volume (rCBV) mapping to improve accuracy in assessing residual enhancing tumors, differentiating sellar lesions, and guiding surgical and therapeutic management. Products are designed for PACS compatibility and clinical implementation in hospital radiology departments and neuro-oncology centers. The company serves academic medical centers, community hospitals, and research institutions internationally, with particular strength in European and North American markets. Imaging Biometrics emphasizes clinical validation through peer-reviewed publications and collaborations with academic neuroradiologists and neuro-oncologists. Software is available as Mac plugins with free trial and demonstration options. The company maintains direct clinical support and works with institutional research teams on imaging-guided surgical planning and radiation therapy applications.

Standard Imaging, Inc. is a manufacturer of radiation calibration and quality assurance instruments for medical physics and radiation therapy applications. Founded in 1989 and headquartered in Middleton, Wisconsin, the company specializes in precision dosimetry solutions, detectors, phantoms, and QA software for cancer treatment centers and diagnostic imaging facilities. Their product portfolio includes electrometers, Exradin scintillation and ionization chambers, water phantoms, and comprehensive QA systems for daily, monthly, and annual quality assurance protocols across linear accelerators, stereotactic radiosurgery systems, CT/CBCT scanners, and diagnostic imaging equipment. Standard Imaging's instruments are utilized in 98 of the top 100 U.S. cancer treatment centers and distributed across 80+ countries. The company emphasizes NIST-traceable absolute dosimetry, patient dosimetry solutions, and regulatory compliance (TG-142 standards). They also provide calibration services, inspection and testing, and software licensing agreements supporting clinical workflow optimization and uncompromising measurement precision.